You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TCR

Showing 1 - 25 of 702
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Safety and Efficacy of TCR-like CAR-T Trial in Nanjing (TCR-like CAR-T)

Recruiting
  • Safety and Efficacy of TCR-like CAR-T
  • TCR-like CAR-T
  • Nanjing, Jiangsu, China
    Zhongda hospital
Jul 26, 2023

Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Beijing (68Ga-TCR-FAPI PET/CT)

Recruiting
  • Malignant Tumor
  • +2 more
  • 68Ga-TCR-FAPI PET/CT
  • Beijing, China
    Peking University Cancer Hospital
Oct 19, 2023

EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV Infection After Allogenic HSCT
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 3, 2023

EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV-associated Hemophagocytic Lymphohistiocytosis
  • EBV Infection
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 12, 2023

HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

Not yet recruiting
  • HPV-Associated Cervical Carcinoma
  • +16 more
  • Conditioning, E7 TCR-T cells, and aldesleukin
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 17, 2023

Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

Not yet recruiting
  • Myeloma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

Not yet recruiting
  • Synovial Sarcoma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))

Recruiting
  • Pancreatic Cancer
  • TCR-T Cells Injection（GB3010 Cells Injection）
  • ShangHai, Shanghai, China
    Ruijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Sep 19, 2023

Chronic Hepatitis B Trial in Beijing (TCR-T)

Active, not recruiting
  • Chronic Hepatitis B
  • TCR-T
  • Beijing, China
    The Fifth Medical Center of PLA General Hospital
Jun 13, 2023

Advanced Soft-tissue Sarcoma Trial in Shenzhen (NY-ESO-1 TCR-T)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • NY-ESO-1 TCR-T
  • Shenzhen, Guangdong, China
    Li Yu
Nov 17, 2022

Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Autologous Mesothelin-specific TCR-T Cells
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 31, 2023

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer Trial in Shanghai (Fludarabine + Cyclophosphamide,

Not yet recruiting
  • Cervical Cancer
  • +6 more
  • Fludarabine + Cyclophosphamide
  • HRYZ-T101 TCR-T Cell
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 27, 2023

Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • PK Blood Collection
  • +2 more
  • (no location specified)
Nov 1, 2022

Preclinical Research for Personalized TCR-T Therapy for Head and

Recruiting
  • Head and Neck Cancer
  • No intervention
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Jan 15, 2023

Solid Tumors Trial (TCR-T cells, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumors
  • TCR-T cells
  • +4 more
  • (no location specified)
Dec 12, 2022

Pancreatic Cancer Trial in Guangzhou (TCR-T therapy)

Recruiting
  • Pancreatic Cancer
  • TCR-T therapy
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 10, 2022

Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Aldesleukin
  • +12 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 9, 2023

TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSH01 injection)

Recruiting
  • TCR-T Cells
  • +2 more
  • KSH01 injection
  • Nanning, Guang XI, China
    The first affiliated hospital of Guang Xi medical university
Sep 14, 2022

Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)

Recruiting
  • Cervical Carcinoma
  • TC-E202 cells
  • +3 more
  • Chongqing, Chongqing, China
    Xiaochun Cheng
Oct 20, 2022

Malignant Epithelial Tumors Trial in Portland (TCR-transduced T cells, CDX-1140, Pembrolizumab)

Not yet recruiting
  • Malignant Epithelial Neoplasms
  • TCR-transduced T cells
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Apr 22, 2022

Celiac Disease Trial in Boston (Gluten Powder)

Recruiting
  • Celiac Disease
  • Gluten Powder
  • Boston, Massachusetts
    Celiac Research Centre Mass General Hospital
Jul 1, 2022

Pancreatic Cancer, Pancreatic Tumors, Pancreatic Ductal Adenocarcinoma Trial in Shanghai (Cyclophosphamide, Fludarabine, Mutant

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Shanghai, China
    Changhai Hospital
Jun 13, 2022

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Cervical Cancer, Anal Cancer, Head Neck Cancers Trial in Zhengzhou (Fludarabine + Cyclophosphamide, Interleukin-2, CRTE7A2-01

Recruiting
  • Cervical Cancer
  • +2 more
  • Fludarabine + Cyclophosphamide
  • +2 more
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Jun 22, 2022

Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

Recruiting
  • Kidney Cancer
  • cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 2, 2022